Study Designs Flashcards

1
Q

Clinical Trial/Randomised Controlled Trial

A

> often used to compare new treatment to control.
gold standard for assessing effectiveness and safety of treatments

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are Complex Intervention trials

A

> similar to clinical
instead assesses non-drug treatments
psychological or educational etc.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Long-Term Follow-up

A

> Usually follows a clinical trial
less controlled than actual trial
long-term outcomes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Record Linkage Study

A

> uses routinely collected data to compare treatments and outcomes
Usually based on routine care
not as strict as clinical trial
Cost-effective
can be lots of variability/missing data

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Observational Study

A

> collecting data on patients throughout their care, without any intervention.
Real-world data
cheaper
less controlled

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Cohort Study

A

> recruit a cohort of a similar demographic anf follow over time
if for an extended period, can collect invaluable data

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Case-Control Study

A

> recruit people with a disease and match to similar people without the disease
Ask them about previous exposures in their lives, related to the disease
retrospective; unreliable

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Epidemiological Study

A

> large population-level studies of disease
assessing transmission and risk factors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Survey/Questionnaire

A

> sample of people recruited to report their views on a particular subject.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Clinical trial phase 1

A

> for cancer studies, terminally ill patients
otherwise, healthy volunteers
safety and dose-finding
very small

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Phase 2 clinical trial

A

> safety and dose-finding
pilot/feasibility
relatively small
to assess whether larger trial can be done:
1.recruitment
2. study procedures
3. follow-up

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Phase 3 clinical trial

A

> efficacy and safety
definitive
large
strictly monitored
randomised, controlled, blinded

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Clinical trial designs

A
  1. superiority
  2. eqiuvalence/non-inferiority
    3.parallel arm
    4.crossover
    5.cluster
    6.stepped-wedge
    7.adaptive designs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

superiority

A

> is intervention better than control?
control can be placebo or standard care
H0 = no difference

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Equivalence

A

> intervention effectiveness must be within a certain range of the control
two-sided confidence interval

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

non-inferiority

A

> intervention must not be significantly worse than control
more common
one-sided CI
used if new intervention is easier to use or cheaper.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

parallel arm

A

> two+ treatment groups
randomised to experimental or control group
usually blinded
repeated measures
between-group analysis

18
Q

Crossover clinical design

A

> treatments are not expected to cure
patients receive 2 treatments, one after the other.
washout period = carryover effects
patients followed up
within patient analysis = less variability

19
Q

Cluster clinical design

A

> usually parallel arm
clusters, rather than individuals, are randomised.
between group analysis, adjusted for cluster.
avoids contamination between groups.

20
Q

stepped-wedge clinical design

A

> all patients start on control
patients randomised to which wave they start the treatment in.
usually done for logistical reasons
individually or cluster randomised
time may be confounding factor
adjust for cluster and wave in analysis

21
Q

clinical adaptive designs

A

> usually parallel arm
dose finding; eliminate less effective does
safety: high toxicity = reduce does or end study.
complex and not often used

22
Q

why do we use controls?

A

> avoid placebo effects
adjust for change over time; changes not due to treatment will be present in both groups

23
Q

why do we randomise patients to treatments?

A

> ensure balance
avoid placebo effects (equally experienced by both groups) and bias
enable attribution of treatment effect

24
Q

methods of randomisation

A

> computer program
blocking
stratification/minimisation
phone/web-based randomisation system

25
Stratification
>splits pool of patients into groups defined by stratification factor e.g. sex, age. >ensures treatment allocation is equal across all factor levels
26
Minimisation
>you can have more than one stratification factor >minimisation ensures balance across all stratification factors between treatment groups.
27
randomising in a cross-over trial
>randomise order in which treatments are received >deals with time confounding
28
why do we blind trials?
>avoid placebo effects >avoid researcher bias
29
double-blind
patient and clinician blinded
30
single-blind
>patient blinded >statistician or researchers collecting follow-up data may also be blinded
31
If blinding is not possible its....
open-label
32
Primary outcomes
>one or two >directly answers research question >type 1 error
33
Secondary outcomes
>usually multiple >less important
34
Objective outcomes
>death, heart attack, disease progression, hospital admission >severe >unlikely to be impacted by placebo effect
35
subjective outcomes
>pain, quality of life, exercise level >more likely to be impacted by placebo effect >can be biased and would ideally be complemented by objective measure
36
composite outcomes
>several event types combines >first occurrence of any event type constitutes event >more events=higher precision for intervention effect >individual events should be considered as secondary outcomes
37
continuous outcome hypothesis testing kit
> Parametric = t-test, ANOVA > non-parametric = mann-whitney, kruskal-wallis
38
hypothesis testing categorical outcome
>chi-squared (proportions) >Fisher's test >mann-whitney for ordinal data
39
Regression modelling hypothesis testing
>linear >logistic >random/mixed effects (repeated measures)
40
Survival analysis hypothesis testing
>time to event >kaplan-meier survival curves >cox hazards modelling
41